We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Pharmaceuticals » Research and Development

Research and Development
%{topic} RSS Feed RSS

Pregnant Woman

Pfizer and BioNTech Test COVID-19 Vaccine in Pregnant Women

February 22, 2021
The phase 2/3 study will also attempt to determine if the women transfer protective antibodies to their babies. Read More

AstraZeneca’s COVID-19 Vaccine More Effective When Given 12 Weeks Apart, Analysis Finds

February 22, 2021
An analysis by researchers at the University of Oxford has found that the AstraZeneca (AZ)/Oxford coronavirus vaccine appears more effective when its two doses are administered three months apart, results in line with those unveiled by AZ earlier this month. Read More

Israeli Study Finds First Dose of Pfizer/BioNTech Vaccine Highly Effective

February 22, 2021
A study conducted in Israel, which has already vaccinated a large percentage of its population, has found that a single dose of Pfizer/BioNTech’s COVID-19 vaccine is highly effective at reducing infection, lending more support to the strategy of delaying second doses to increase initial vaccinations. Read More

Novartis Partners With Gates Foundation for Sickle Cell Therapy

February 19, 2021
The effort aims to deliver a gene therapy that eliminates the need to modify cells in a lab. Read More

Pfizer/BioNTech Evaluate COVID-19 Vaccine in Pregnant Women

February 19, 2021
Pfizer and BioNTech announced that they have dosed the first patients in a global study evaluating their COVID-19 vaccine in pregnant women 18 years and over. Read More

Fujifilm’s Avigan Shows Limited Efficacy Against Symptomatic COVID-19, Analysis Finds

February 19, 2021
A statistical analysis of multiple clinical trials that assessed Fujifilm’s antiviral Avigan (favipiravir) as a COVID-19 treatment has found that the drug showed limited efficacy in reducing mortality unless given early to infected patients. Read More

Researchers Call for Delaying Second Dose of Pfizer’s Vaccine, Finding Initial Dose Highly Effective

February 19, 2021
The U.S. should postpone second doses of the Pfizer/BioNTech COVID-19 vaccine in order to conserve supply and inoculate as many people as possible, two Canadian researchers recommended, citing data showing the initial dose to be highly effective. Read More

UK to Start World’s First COVID-19 Human Challenge Trial

February 18, 2021
A specially convened UK clinical trial ethics committee has given the go-ahead for a COVID-19 human challenge study that is slated to start within weeks to help inform further vaccine and treatment research. Read More

AstraZeneca Says Modified COVID-19 Vaccine Could Take Half a Year or More

February 16, 2021
Efforts to reach large-scale production of a COVID-19 vaccine modified to address new viral variants could take AstraZeneca (AZ) at least six months to achieve, according to company documents. Read More

Roche’s Arthritis Drug Reduces COVID-19 Deaths in UK Trial

February 16, 2021
Roche’s anti-inflammatory drug Actemra (tocilizumab) has been shown to reduce COVID-19-related deaths in the UK’s RECOVERY trial of multiple potential treatments. Read More

Oxford Initiates First Study of Its COVID-19 Vaccine in Children

February 16, 2021
The University of Oxford has announced that it has begun the first study of the AstraZeneca (AZ)/Oxford coronavirus vaccine in children and young adults to evaluate if the inoculation is safe and effective in patients aged six to 17. Read More

Prescription Asthma Med Slashes COVID-19 Hospitalization

February 12, 2021
Patients receiving budesonide also enjoyed a decrease in fever and persistent symptoms, according to the study results posted on the pre-print server medRxiv. Read More
Previous 1 2 3 4 5 6 7 8 9 … 197 198 Next

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing